GGV Capital has led a Series A+ round of nearly 100 million yuan ($14 million) in Chinese tax and accounting startup Rongyisuan, while Beijing-based Hugo Biotech has also raised almost 100 million yuan ($14 million) in its first funding round.
GGV leads funding in accounting solutions provider Rongyisuan
Rongyisuan, a Chinese startup that provides customized tax and accounting solutions for corporate customers, has raised nearly 100 million yuan ($14 million) in a Series A+ round of financing led by global venture capital firm GGV Capital.
